Global cancer treatment market grew to $107 billion in 2015: Report

More than 20 tumor types are being treated with one or more of the 70 new cancer treatments that have been launched in the past five years, with the sustained surge in innovative therapies driving the global oncology market to $107 billion in 2015.

However, many of these drugs are not yet available to patients in most countries, and even when registered they may not be reimbursed under public insurance programs, according to a new study released today by the IMS Institute for Healthcare Informatics.

The study - Global Oncology Trend Report: A Review of 2015 and Outlook to 2020 - finds that growth in global spending on oncology therapeutics and supportive care drugs increased 11.5% on a constant-dollar basis last year. Growth is measured using ex-manufacturer prices and does not reflect off-invoice discounts, rebates or patient access programs